Report date: Nov 6,2024 Conflict count: 361874 Publisher: Wiley (Blackwell Publishing) Title count: 475 Conflict count: 16773 ========================================================== Created: 2023-10-10 19:58:25 ConfID: 6959816 CauseID: 1592510653 OtherID: 165167019 JT: Epilepsia MD: Grabenbauer,46,3,457,2005,Gamma Knife Surgery in Mesial Temporal Lobe Epilepsy DOI: 10.1111/j.0013-9580.2005.t01-1-53904.x(Journal) (6959816-N) DOI: 10.1111/j.0013-9580.2005.53904.x(Journal) ========================================================== Created: 2023-10-10 20:00:34 ConfID: 6959826 CauseID: 1592511228 OtherID: 213586904 JT: Epilepsia MD: ,46,10,1557,2005,Basic Science DOI: 10.1111/j.1528-1167.2005.00105.x(Journal) (6959826-N) DOI: 10.1111/j.1528-1167.2005.00105_1.x(Journal) ========================================================== Created: 2023-10-10 19:53:52 ConfID: 6959802 CauseID: 1592509514 OtherID: 267759700 JT: Epilepsia MD: Ngoungou,47,5,873,2006,Epilepsy as a Consequence of Cerebral Malaria in Area in Which Malaria Is Endemic in Mali, West Africa DOI: 10.1111/j.1528-1167.2006.00524.x(Journal) (6959802-N) DOI: 10.1111/j.0013-9580.2006.00558.x(Journal) ========================================================== Created: 2009-04-03 08:42:08 ConfID: 4798572 CauseID: 767228023 OtherID: 769166818 JT: Epilepsia MD: ,50,4,971,2009,ERRATA DOI: 10.1111/j.1528-1167.2009.02138_2.x(Journal) (4798572-N) DOI: 10.1111/j.1528-1167.2009.02138_1.x(Journal) ========================================================== Created: 2023-10-13 18:30:33 ConfID: 6961408 CauseID: 1592898178 OtherID: 139357256 JT: Epilepsia MD: Derakhshan,45,6,715,2004,Late Language Transfer vs. Immutability of Command Center DOI: 10.1111/j.0013-9580.2004.t01-1-70103.x(Journal) (6961408-N) DOI: 10.1111/j.0013-9580.2004.70103.x(Journal) ========================================================== Created: 2023-10-16 18:44:53 ConfID: 6964154 CauseID: 1593265334 OtherID: 139355222 JT: Epilepsia MD: Danielsen,42,2,288,2001,Lactate and Other Metabolic Changes in Neuronal Migration Disorders DOI: 10.1046/j.1528-1157.2001.29300-3.x(Journal) (6964154-N) DOI: 10.1111/j.1528-1167.2001.29300-3.x(Journal) ========================================================== Created: 2023-10-16 18:44:53 ConfID: 6964155 CauseID: 1593265334 OtherID: 139355222 JT: Epilepsia MD: Simone,42,2,288,2001,Reply DOI: 10.1046/j.1528-1157.2001.29300-4.x(Journal) (6964155-N) DOI: 10.1111/j.1528-1167.2001.29300-4.x(Journal) ========================================================== Created: 2023-10-16 18:44:53 ConfID: 6964153 CauseID: 1593265334 OtherID: 139355222 JT: Epilepsia MD: Osorio,42,2,288,2001,Refractory Idiopathic Status Epilepticus DOI: 10.1046/j.1528-1157.2001.29300-2.x(Journal) (6964153-N) DOI: 10.1111/j.1528-1167.2001.29300-2.x(Journal) ========================================================== Created: 2023-10-16 18:44:53 ConfID: 6964156 CauseID: 1593265334 OtherID: 139355222 JT: Epilepsia MD: Lhatoo,42,2,288,2001,Reply DOI: 10.1046/j.1528-1157.2001.29300-6.x(Journal) (6964156-N) DOI: 10.1111/j.1528-1167.2001.29300-6.x(Journal) ========================================================== Created: 2023-10-16 18:44:53 ConfID: 6964157 CauseID: 1593265334 OtherID: 139355222 JT: Epilepsia MD: DeToledo,42,2,288,2001,Cardiac Arrest After Fast Intravenous Infusion of Phenytoin Mistaken for Fosphenytoin DOI: 10.1046/j.1528-1157.2001.29300.x(Journal) (6964157-N) DOI: 10.1111/j.1528-1167.2001.29300.x(Journal) ========================================================== Created: 2023-09-25 14:31:21 ConfID: 6935465 CauseID: 1590641296 OtherID: 139756933 JT: Epilepsia MD: Ferrendelli,42,s4,28,2001,Concerns with Antiepileptic Drug Initiation: Safety, Tolerability, and Efficacy DOI: 10.1046/j.1528-1157.2001.0420s4028.x(Journal) (6935465-N) DOI: 10.1111/j.1528-1167.2001.00006.x(Journal) ========================================================== Created: 2023-09-25 14:31:21 ConfID: 6935464 CauseID: 1590641296 OtherID: 139756933 JT: Epilepsia MD: Radtke,42,s4,24,2001,Pharmacokinetics of Levetiracetam DOI: 10.1046/j.1528-1157.2001.0420s4024.x(Journal) (6935464-N) DOI: 10.1111/j.1528-1167.2001.00005.x(Journal) ========================================================== Created: 2023-09-25 14:31:21 ConfID: 6935467 CauseID: 1590641296 OtherID: 139756933 JT: Epilepsia MD: Harden,42,s4,36,2001,Safety Profile of Levetiracetam DOI: 10.1046/j.1528-1157.2001.0420s4036.x(Journal) (6935467-N) DOI: 10.1111/j.1528-1167.2001.00008.x(Journal) ========================================================== Created: 2023-09-25 14:31:21 ConfID: 6935466 CauseID: 1590641296 OtherID: 139756933 JT: Epilepsia MD: Privitera,42,s4,31,2001,Efficacy of Levetiracetam: A Review of Three Pivotal Clinical Trials DOI: 10.1046/j.1528-1157.2001.0420s4031.x(Journal) (6935466-N) DOI: 10.1111/j.1528-1167.2001.00007.x(Journal) ========================================================== Created: 2023-09-25 14:31:21 ConfID: 6935468 CauseID: 1590641296 OtherID: 139756933 JT: Epilepsia MD: French,42,s4,40,2001,Use of Levetiracetam in Special Populations DOI: 10.1046/j.1528-1157.2001.0420s4040.x(Journal) (6935468-N) DOI: 10.1111/j.1528-1167.2001.00009.x(Journal) ========================================================== Created: 2023-09-25 14:31:21 ConfID: 6935459 CauseID: 1590641296 OtherID: 139756933 JT: Epilepsia MD: Leppik,42,s4,44,2001,The Place of Levetiracetam in the Treatment of Epilepsy DOI: 10.1046/j.1528-1157.2001.0420s4044.x(Journal) (6935459-N) DOI: 10.1111/j.1528-1167.2001.00010.x(Journal) ========================================================== Created: 2023-09-25 14:31:21 ConfID: 6935461 CauseID: 1590641296 OtherID: 139756933 JT: Epilepsia MD: Kupferberg,42,s4,7,2001,Animal Models Used in the Screening of Antiepileptic Drugs DOI: 10.1046/j.1528-1157.2001.0420s4007.x(Journal) (6935461-N) DOI: 10.1111/j.1528-1167.2001.00002.x(Journal) ========================================================== Created: 2023-09-25 14:31:21 ConfID: 6935460 CauseID: 1590641296 OtherID: 139756933 JT: Epilepsia MD: Leppik,42,s4,1,2001,Issues in the Treatment of Epilepsy DOI: 10.1046/j.1528-1157.2001.0420s4001.x(Journal) (6935460-N) DOI: 10.1111/j.1528-1167.2001.00001.x(Journal) ========================================================== Created: 2023-09-25 14:31:21 ConfID: 6935463 CauseID: 1590641296 OtherID: 139756933 JT: Epilepsia MD: Faught,42,s4,19,2001,Pharmacokinetic Considerations in Prescribing Antiepileptic Drugs DOI: 10.1046/j.1528-1157.2001.0420s4019.x(Journal) (6935463-N) DOI: 10.1111/j.1528-1167.2001.00004.x(Journal) ========================================================== Created: 2023-09-25 14:31:21 ConfID: 6935462 CauseID: 1590641296 OtherID: 139756933 JT: Epilepsia MD: Klitgaard,42,s4,13,2001,Levetiracetam: The Preclinical Profile of a New Class of Antiepileptic Drugs? DOI: 10.1046/j.1528-1157.2001.0420s4013.x(Journal) (6935462-N) DOI: 10.1111/j.1528-1167.2001.00003.x(Journal) ========================================================== Created: 2023-09-25 14:35:54 ConfID: 6935483 CauseID: 1590642669 JT: Epilepsia MD: ,44,s9,4,2003,December 8, 2003 DOI: 10.1046/j.1528-1157.44.s9.3.x(Journal) (6935483-N) DOI: 10.1046/j.1528-1157.44.s9.4.x(Journal) ========================================================== Created: 2023-09-25 14:28:57 ConfID: 6935440 CauseID: 1590640587 JT: Epilepsia MD: ,35,s1,,1994,Panel Discussion DOI: 10.1111/j.1528-1157.1994.tb05930.x(Journal) (6935440-N) DOI: 10.1111/j.1528-1157.1994.tb05927.x(Journal) ========================================================== Created: 2023-09-25 14:36:41 ConfID: 6935966 CauseID: 1590642917 JT: Epilepsia MD: ,28,s1,,1987,Discussion DOI: 10.1111/j.1528-1157.1987.tb05762.x(Journal) (6935966-N) DOI: 10.1111/j.1528-1157.1987.tb05756.x(Journal) DOI: 10.1111/j.1528-1157.1987.tb05746.x(Journal) DOI: 10.1111/j.1528-1157.1987.tb05760.x(Journal) DOI: 10.1111/j.1528-1157.1987.tb05748.x(Journal) DOI: 10.1111/j.1528-1157.1987.tb05749.x(Journal) DOI: 10.1111/j.1528-1157.1987.t ========================================================== Created: 2023-09-25 14:47:38 ConfID: 6936711 CauseID: 1590646231 OtherID: 14417365 JT: Epilepsia MD: Mayanagi,43,s9,1,2002,Preface DOI: 10.1046/j.1528-1157.43.s9.1.x(Journal) (6936711-N) DOI: 10.1046/j.1528-1157.43.s9.5.x(Journal) ========================================================== Created: 2023-09-26 09:05:29 ConfID: 6937337 CauseID: 1590768401 OtherID: 14417126 JT: Epilepsia MD: Sato,42,s6,1,2001,Preface DOI: 10.1046/j.1528-1157.2001.0420s6001.x(Journal) (6937337-N) DOI: 10.1046/j.1528-1157.42.s6.12.x(Journal) ========================================================== Created: 2023-09-26 09:05:29 ConfID: 6937336 CauseID: 1590768401 OtherID: 14417126 JT: Epilepsia MD: Matsuoka,42,s6,42,2001,Neuropsychology of Epilepsy DOI: 10.1046/j.1528-1157.2001.0420s6042.x(Journal) (6937336-N) DOI: 10.1046/j.1528-1157.42.s6.8.x(Journal) ========================================================== Created: 2023-09-26 09:05:33 ConfID: 6937339 CauseID: 1590768444 OtherID: 14417143 JT: Epilepsia MD: Willmore,42,s8,6,2001,Treatment of Benign Epilepsy Syndromes Throughout Life DOI: 10.1046/j.1528-1157.2001.0420s8006.x(Journal) (6937339-N) DOI: 10.1046/j.1528-1157.42.s8.5.x(Journal) ========================================================== Created: 2023-09-26 09:05:33 ConfID: 6937338 CauseID: 1590768444 OtherID: 14417143 JT: Epilepsia MD: Faught,42,s8,4,2001,The Challenge of Treatment Selection for Epilepsy DOI: 10.1046/j.1528-1157.2001.0420s8004.x(Journal) (6937338-N) DOI: 10.1046/j.1528-1157.42.s8.4.x(Journal) ========================================================== Created: 2023-09-26 09:05:33 ConfID: 6937341 CauseID: 1590768444 OtherID: 14417143 JT: Epilepsia MD: Boggs,42,s8,18,2001,Elderly Patients with Systemic Disease DOI: 10.1046/j.1528-1157.2001.0420s8018.x(Journal) (6937341-N) DOI: 10.1046/j.1528-1157.42.s8.7.x(Journal) ========================================================== Created: 2023-09-26 09:05:33 ConfID: 6937340 CauseID: 1590768444 OtherID: 14417143 JT: Epilepsia MD: Nordli,42,s8,10,2001,Special Needs of the Adolescent with Epilepsy DOI: 10.1046/j.1528-1157.2001.0420s8010.x(Journal) (6937340-N) DOI: 10.1046/j.1528-1157.42.s8.6.x(Journal) ========================================================== Created: 2023-09-26 09:05:33 ConfID: 6937342 CauseID: 1590768444 OtherID: 14417143 JT: Epilepsia MD: Loring,42,s8,24,2001,Cognitive and Behavioral Effects of Epilepsy Treatment DOI: 10.1046/j.1528-1157.2001.0420s8024.x(Journal) (6937342-N) DOI: 10.1046/j.1528-1157.42.s8.8.x(Journal) ========================================================== Created: 2023-09-26 09:05:29 ConfID: 6937329 CauseID: 1590768401 OtherID: 14417126 JT: Epilepsia MD: Wada,42,s6,2,2001,Predisposed Susceptibility and Partial Seizure Disorder DOI: 10.1046/j.1528-1157.2001.0420s6002.x(Journal) (6937329-N) DOI: 10.1046/j.1528-1157.42.s6.11.x(Journal) ========================================================== Created: 2023-09-26 09:05:29 ConfID: 6937331 CauseID: 1590768401 OtherID: 14417126 JT: Epilepsia MD: Wachi,42,s6,4,2001,Neuropsychological Changes After Surgical Treatment for Temporal Lobe Epilepsy DOI: 10.1046/j.1528-1157.2001.0420s6004.x(Journal) (6937331-N) DOI: 10.1046/j.1528-1157.42.s6.1.x(Journal) ========================================================== Created: 2023-09-26 09:05:29 ConfID: 6937330 CauseID: 1590768401 OtherID: 14417126 JT: Epilepsia MD: Engel,42,s6,3,2001,Intractable Epilepsy: Definition and Neurobiology DOI: 10.1046/j.1528-1157.2001.0420s6003.x(Journal) (6937330-N) DOI: 10.1046/j.1528-1157.42.s6.10.x(Journal) ========================================================== Created: 2023-09-26 09:05:29 ConfID: 6937333 CauseID: 1590768401 OtherID: 14417126 JT: Epilepsia MD: Mayanagi,42,s6,19,2001,Psychiatric and Neuropsychological Problems in Epilepsy Surgery: Analysis of 100 Cases That Underwent Surgery DOI: 10.1046/j.1528-1157.2001.05405.x(Journal) (6937333-N) DOI: 10.1046/j.1528-1157.2001.0420s6019.x(Journal) ========================================================== Created: 2023-09-26 09:05:29 ConfID: 6937332 CauseID: 1590768401 OtherID: 14417126 JT: Epilepsia MD: Inoue,42,s6,13,2001,Psychiatric Disorders Before and After Surgery for Epilepsy DOI: 10.1046/j.1528-1157.2001.0420s6013.x(Journal) (6937332-N) DOI: 10.1046/j.1528-1157.42.s6.3.x(Journal) ========================================================== Created: 2023-09-26 09:05:29 ConfID: 6937335 CauseID: 1590768401 OtherID: 14417126 JT: Epilepsia MD: Kameyama,42,s6,37,2001,Surgical Strategy and Outcomes for Epileptic Patients with Focal Cortical Dysplasia or Dysembryoplastic Neuroepithelial Tumor DOI: 10.1046/j.1528-1157.2001.0420s6037.x(Journal) (6937335-N) DOI: 10.1046/j.1528-1157.42.s6.7.x(Journal) ========================================================== Created: 2023-09-26 09:05:29 ConfID: 6937334 CauseID: 1590768401 OtherID: 14417126 JT: Epilepsia MD: Matsuda,42,s6,29,2001,Neuroradiologic Findings in Focal Cortical Dysplasia: Histologic Correlation with Surgically Resected Specimens DOI: 10.1046/j.1528-1157.2001.0420s6029.x(Journal) (6937334-N) DOI: 10.1046/j.1528-1157.42.s6.6.x(Journal) ========================================================== Created: 2023-09-26 08:54:49 ConfID: 6937243 CauseID: 1590765247 OtherID: 201422585 JT: Epilepsia MD: Jibiki,41,s9,59,2000,Regional Relationships Between Focal Abnormalities on SPECTs and High Power Zones on EEG Topographies of Background H Activities in Adult Patients with Partial Epilepsies DOI: 10.1111/j.1528-1157.2000.tb02245.x(Journal) (6937243-N) DOI: 10.1111/j.1528-1157.2000.tb02244.x(Journal) ========================================================== Created: 2023-09-26 09:07:16 ConfID: 6937366 CauseID: 1590768940 JT: Epilepsia MD: ,40,s1,,1999,Panel Discussion DOI: 10.1111/j.1528-1157.1999.tb00881.x(Journal) (6937366-N) DOI: 10.1111/j.1528-1157.1999.tb00874.x(Journal) DOI: 10.1111/j.1528-1157.1999.tb00877.x(Journal) ========================================================== Created: 2019-04-04 18:52:53 ConfID: 5463283 CauseID: 1442555491 OtherID: 139756937 JT: Epilepsia MD: Groden,42,s5,2,2001,Overview of Genetics for the Clinician DOI: 10.1046/j.1528-1157.2001.0420s5002.x(Journal) (5463283-N) DOI: 10.1111/j.1528-1167.2001.0s001.x(Journal) ========================================================== Created: 2019-04-04 18:52:53 ConfID: 5463282 CauseID: 1442555491 OtherID: 139756937 JT: Epilepsia MD: Ottman,42,s5,24,2001,Progress in the Genetics of the Partial Epilepsies DOI: 10.1046/j.1528-1157.2001.0420s5024.x(Journal) (5463282-N) DOI: 10.1111/j.1528-1167.2001.0s005.x(Journal) ========================================================== Created: 2019-04-04 18:52:53 ConfID: 5463281 CauseID: 1442555491 OtherID: 139756937 JT: Epilepsia MD: Noebels,42,s5,11,2001,Modeling Human Epilepsies in Mice DOI: 10.1046/j.1528-1157.2001.0420s5011.x(Journal) (5463281-N) DOI: 10.1111/j.1528-1167.2001.0s002.x(Journal) ========================================================== Created: 2019-04-04 18:52:53 ConfID: 5463280 CauseID: 1442555491 OtherID: 139756937 JT: Epilepsia MD: Berkovic,42,s5,16,2001,Genetics of the Epilepsies DOI: 10.1046/j.1528-1157.2001.0420s5016.x(Journal) (5463280-N) DOI: 10.1111/j.1528-1167.2001.0s003.x(Journal) ========================================================== Created: 2019-04-04 18:54:10 ConfID: 5463287 CauseID: 1442555524 OtherID: 139357174 JT: Epilepsia MD: Mikati,45,3,296,2004,Neuronal Cell Death in a Rat Model of Mesial Temporal Lobe Epilepsy Is Induced by the Initial Status Epilepticus and Not by Later Repeated Spontaneous Seizures DOI: 10.1111/j.0013-9580.2004.t01-1-58503.x(Journal) (5463287-N) DOI: 10.1111/j.0013-9580.2004.58503.x(Journal) ========================================================== Created: 2019-04-04 18:52:53 ConfID: 5463284 CauseID: 1442555491 OtherID: 139756937 JT: Epilepsia MD: Privitera,42,s5,1,2001,Introduction DOI: 10.1046/j.1528-1157.2001.0420s5001.x(Journal) (5463284-N) DOI: 10.1111/j.1528-1167.2001.042s5.x(Journal) ========================================================== Created: 2019-04-04 18:50:39 ConfID: 5463275 CauseID: 1442555451 OtherID: 14417299 JT: Epilepsia MD: French,43,s10,1,2002,Foreward DOI: 10.1046/j.1528-1157.43.s10.1.x(Journal) (5463275-N) DOI: 10.1046/j.1528-1157.43.s10.3.x(Journal) ========================================================== Created: 2019-04-04 18:52:53 ConfID: 5463279 CauseID: 1442555491 OtherID: 139756937 JT: Epilepsia MD: Roden,42,s5,44,2001,Principles in Pharmacogenetics DOI: 10.1046/j.1528-1157.2001.0420s5044.x(Journal) (5463279-N) DOI: 10.1111/j.1528-1167.2001.0s008.x(Journal) ========================================================== Created: 2019-04-04 18:52:53 ConfID: 5463278 CauseID: 1442555491 OtherID: 139756937 JT: Epilepsia MD: Cooper,42,s5,49,2001,Potassium Channels: How Genetic Studies of Epileptic Syndromes Open Paths to New Therapeutic Targets and Drugs DOI: 10.1046/j.1528-1157.2001.0420s5049.x(Journal) (5463278-N) DOI: 10.1111/j.1528-1167.2001.0s009.x(Journal) ========================================================== Created: 2019-04-04 18:52:53 ConfID: 5463277 CauseID: 1442555491 OtherID: 139756937 JT: Epilepsia MD: Spear,42,s5,31,2001,Pharmacogenetics and Antiepileptic Drugs DOI: 10.1046/j.1528-1157.2001.0420s5031.x(Journal) (5463277-N) DOI: 10.1111/j.1528-1167.2001.0s006.x(Journal) ========================================================== Created: 2019-04-04 18:52:53 ConfID: 5463276 CauseID: 1442555491 OtherID: 139756937 JT: Epilepsia MD: Ptacek,42,s5,35,2001,Channelopathies: Episodic Disorders of the Nervous System DOI: 10.1046/j.1528-1157.2001.0420s5035.x(Journal) (5463276-N) DOI: 10.1111/j.1528-1167.2001.0s007.x(Journal)